DekaBank Deutsche Girozentrale boosted its holdings in Crocs, Inc. (NASDAQ:CROX - Free Report) by 477.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,246 shares of the textile maker's stock after buying an additional 9,300 shares during the quarter. DekaBank Deutsche Girozentrale's holdings in Crocs were worth $1,614,000 at the end of the most recent reporting period.
Several other hedge funds have also added to or reduced their stakes in the business. National Bank of Canada FI raised its position in shares of Crocs by 8,437.1% during the second quarter. National Bank of Canada FI now owns 182,695 shares of the textile maker's stock worth $26,993,000 after acquiring an additional 180,555 shares during the last quarter. Pacer Advisors Inc. lifted its position in shares of Crocs by 15.1% in the 2nd quarter. Pacer Advisors Inc. now owns 1,091,097 shares of the textile maker's stock worth $159,235,000 after purchasing an additional 142,944 shares during the period. Marshall Wace LLP bought a new stake in shares of Crocs in the 2nd quarter valued at $19,598,000. LSV Asset Management increased its position in shares of Crocs by 73.3% during the first quarter. LSV Asset Management now owns 300,413 shares of the textile maker's stock worth $43,199,000 after buying an additional 127,100 shares during the period. Finally, Distillate Capital Partners LLC bought a new position in Crocs during the second quarter worth $13,483,000. 93.44% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of brokerages have weighed in on CROX. Piper Sandler reiterated an "overweight" rating and set a $170.00 price target on shares of Crocs in a report on Friday, August 23rd. Guggenheim decreased their target price on Crocs from $182.00 to $155.00 and set a "buy" rating for the company in a research note on Wednesday. Barclays dropped their price target on Crocs from $164.00 to $125.00 and set an "overweight" rating on the stock in a research note on Tuesday. Robert W. Baird reduced their price objective on shares of Crocs from $190.00 to $180.00 and set an "outperform" rating for the company in a research report on Wednesday. Finally, Loop Capital lowered their price objective on shares of Crocs from $155.00 to $150.00 and set a "buy" rating for the company in a research note on Wednesday. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $154.00.
Check Out Our Latest Analysis on Crocs
Crocs Stock Down 1.5 %
NASDAQ CROX traded down $1.61 during trading hours on Friday, hitting $106.21. The company's stock had a trading volume of 1,880,424 shares, compared to its average volume of 1,333,763. The company has a market capitalization of $6.19 billion, a PE ratio of 7.70, a price-to-earnings-growth ratio of 1.10 and a beta of 2.01. The company has a current ratio of 1.43, a quick ratio of 0.95 and a debt-to-equity ratio of 0.82. Crocs, Inc. has a 52 week low of $74.00 and a 52 week high of $165.32. The company's 50-day simple moving average is $135.60 and its two-hundred day simple moving average is $138.11.
Crocs (NASDAQ:CROX - Get Free Report) last posted its earnings results on Tuesday, October 29th. The textile maker reported $3.60 earnings per share for the quarter, beating analysts' consensus estimates of $3.10 by $0.50. The company had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.05 billion. Crocs had a return on equity of 49.70% and a net margin of 20.50%. The company's revenue for the quarter was up 1.6% on a year-over-year basis. During the same quarter last year, the company earned $3.25 earnings per share. Research analysts anticipate that Crocs, Inc. will post 12.94 EPS for the current fiscal year.
Insider Buying and Selling at Crocs
In other news, Director John B. Replogle acquired 2,240 shares of Crocs stock in a transaction on Wednesday, October 30th. The stock was acquired at an average cost of $112.60 per share, with a total value of $252,224.00. Following the transaction, the director now owns 9,304 shares of the company's stock, valued at approximately $1,047,630.40. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Crocs news, Director John B. Replogle purchased 2,240 shares of the company's stock in a transaction that occurred on Wednesday, October 30th. The shares were acquired at an average cost of $112.60 per share, for a total transaction of $252,224.00. Following the completion of the acquisition, the director now owns 9,304 shares of the company's stock, valued at $1,047,630.40. The trade was a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Douglas J. Treff sold 10,594 shares of the business's stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $132.38, for a total value of $1,402,433.72. Following the completion of the transaction, the director now directly owns 81,254 shares in the company, valued at approximately $10,756,404.52. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.72% of the company's stock.
Crocs Company Profile
(
Free Report)
Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.
Featured Articles
Before you consider Crocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crocs wasn't on the list.
While Crocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.